Newron Pharmaceuticals S.p.A.
Newron Pharmaceuticals S.p.A. (NWPHF) Stock Overview
Explore Newron Pharmaceuticals S.p.A.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
231.2M
P/E Ratio
N/A
EPS (TTM)
N/A
ROE
N/A
NWPHF Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Newron Pharmaceuticals S.p.A. (NWPHF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of N/A.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of N/A and a market capitalization of 231.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.